You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Sunovion to buy Elevation Pharmaceuticals in a deal with a $100m upfront payment

Sunovion Pharmaceuticals Inc., the Marlborough subsidiary of a Japanese drug company, has agreed to buy Elevation­ Pharmaceuticals Inc., a privately held company specializing in the development of aerosol therapies for patients with respiratory diseases.

Sunovion will make an upfront payment of $100 million to shareholders of California-based Elevation when the deal closes. The agreement also calls for milestone payments of up to $90 million if an Elevation Pharmaceuticals drug candidate achieves certain goals. If the drug candidate gets regulatory approval, Sunovion said it could make commercial milestone payments of up to $210 million. Subsequent payments up to $30 million could occur.

Continue reading below

An Elevation drug candidate referenced in the sales agreement is EP-101, a potential treatment for chronic obstructive pulmonary disease.

Sunovion, formerly Sepracor, was bought by Dainippon Sumitomo Pharma in 2009.

Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.